Open official notice

Succinylcholine Chloride Injection, USP 200 mg 10 mL (20 mg mL), Rx only, 10 mL Multiple-dose Vial, Sterile

Official notice

17 Sept 2025

RecallScope risk estimate:MediumFDA

An official FDA notice concerns Succinylcholine Chloride Injection, USP 200 mg 10 mL (20 mg mL), Rx only, 10 mL Multiple-dose Vial, Sterile. Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity. Published 2025-09-17.

What to do now

Do not use the affected product. Contact your healthcare provider or pharmacist and follow the instructions on the official FDA notice.

Units affected

270,125

Recall number

D-0623-2025

Official notice

2025-09-17

The hazard

Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.

How to check if you’re affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Event Ids

97510

Recall Numbers

D-0623-2025

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile, Manufactured by Zydus Lifesciences Ltd, Vadodara, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1377-1 (vial), NDC 70710-1377-2 (carton).

Units affected

270,125

Hazard

Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

US · United States · LA

Location 2

US · United States · MS

Location 3

US · United States · OH

Affected area 1

US · United States

Company & contacts

Manufacturer

Zydus Pharmaceuticals (USA) Inc

Phone

Not provided

Brand: Zydus Pharmaceuticals. Contact: Zydus Pharmaceuticals (USA) Inc.

Source & status

Source

Tier

official

Category

Health

Official classification

Class II

Recall details

Recall number

D-0623-2025

Event ID

97510

Units affected

270,125

Status

active

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week’s recalls before you need them.

One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 17 Sept 2025. The next one won’t wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button